Related Experiment Video
Updated: Jun 22, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
Leveraging Complementary Ion Activation Methods with Proton Transfer Charge Reduction Reactions for Comprehensive
Sean D Dunham1, Kyle J Juetten1, Jessica Hellinger1
1Department of Chemistry, University of Texas, Austin, Texas 78712, United States.
This study enhances large protein characterization using a hybrid mass spectrometry strategy. The new method improves sequence coverage for antibodies and antibody drug conjugates, enabling precise differentiation of isomers.
Area of Science:
- Analytical Chemistry
- Biochemistry
- Proteomics
Background:
- Top-down mass spectrometry of large proteins faces challenges with low signal-to-noise ratios (S/N) and spectral congestion.
- Proton transfer charge reduction (PTCR) aids spectral congestion but struggles with low S/N, necessitating extensive spectral averaging.
Purpose of the Study:
- To advance the characterization of large proteins, including monoclonal antibodies (mAbs) and antibody drug conjugates (ADCs).
- To overcome limitations in S/N and spectral congestion in large protein analysis.
- To achieve high sequence coverage and differentiate complex biopharmaceutical structures.
Main Methods:
- Implementation of a hybrid strategy combining ultraviolet photodissociation (UVPD), electron transfer higher collision energy dissociation (EThcD), and PTCR.
- Utilizing liquid chromatography time scale analysis with purposeful chromatographic peak broadening.
- Employing gas-phase fractionation and complementary activation methods.
Main Results:
- Achieved high sequence coverages of 85% for mAb heavy chain (Hc) and 79% for ADC Hc subunits.
- Successfully differentiated two payload positional isomers of an ADC Hc.
- Demonstrated the effectiveness of the hybrid strategy for large protein characterization.
Conclusions:
- The developed hybrid strategy significantly enhances the characterization of large proteins and complex biopharmaceuticals.
- This approach overcomes key limitations in mass spectrometry-based protein analysis.
- Enables precise structural elucidation and isomer differentiation crucial for biopharmaceutical development.
More Related Videos
10:50Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
Published on: May 1, 2019
04:24Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
Published on: June 16, 2023